Maternal, fetal, neonatal and breastmilk flecainide concentration during maternal therapy and lactation: a case report

BACKGROUND: Mothers requiring the antiarrhythmic agent flecainide are often advised not to breastfeed, because of the lack of data concercing neonatal effects and flecainide plasma concentrations following maternal exposure as well as via lactation. This is the first report on combined maternal, fet...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zande, Johanna A., Cornette, Jérôme M.J., Roos-Hesselink, Jolien W., Flint, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103521/
https://www.ncbi.nlm.nih.gov/pubmed/37060099
http://dx.doi.org/10.1186/s13006-023-00559-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103521/
https://www.ncbi.nlm.nih.gov/pubmed/37060099
http://dx.doi.org/10.1186/s13006-023-00559-z

Ejemplares similares